プロトロンビン複合体濃縮物（PCC）のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Prothrombin Complex Concentrate(PCC) Market Insights, Forecast to 2028

• レポートコード：QY2207E10483 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のプロトロンビン複合体濃縮物（PCC）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にプロトロンビン複合体濃縮物（PCC）の世界市場のxxx％を占める「100IU」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のプロトロンビン複合体濃縮物（PCC）の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのプロトロンビン複合体濃縮物（PCC）市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのプロトロンビン複合体濃縮物（PCC）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 プロトロンビン複合体濃縮物（PCC）のグローバル主要メーカーには、CSL、Beijing Tiantan Biological Products、SHANGHAI RAAS、Biotest、Taibang Biologic Group、HUALAN BIOLOGICAL ENGINEERING、WEIGUANG BIOLOGICAL、Green Cross、BOHUI、Guangdong Shuanglin Biopharmaceutical、Jiangxi Boya Bio-Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 プロトロンビン複合体濃縮物（PCC）市場は、種類と用途によって区分されます。世界のプロトロンビン複合体濃縮物（PCC）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 100IU、200IU、300IU、400IU、1000IU 【用途別セグメント】 病院、クリニック、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - プロトロンビン複合体濃縮物（PCC）製品概要 - 種類別市場（100IU、200IU、300IU、400IU、1000IU） - 用途別市場（病院、クリニック、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のプロトロンビン複合体濃縮物（PCC）販売量予測2017-2028 - 世界のプロトロンビン複合体濃縮物（PCC）売上予測2017-2028 - プロトロンビン複合体濃縮物（PCC）の地域別販売量 - プロトロンビン複合体濃縮物（PCC）の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別プロトロンビン複合体濃縮物（PCC）販売量 - 主要メーカー別プロトロンビン複合体濃縮物（PCC）売上 - 主要メーカー別プロトロンビン複合体濃縮物（PCC）価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（100IU、200IU、300IU、400IU、1000IU） - プロトロンビン複合体濃縮物（PCC）の種類別販売量 - プロトロンビン複合体濃縮物（PCC）の種類別売上 - プロトロンビン複合体濃縮物（PCC）の種類別価格 ・用途別市場規模（病院、クリニック、その他） - プロトロンビン複合体濃縮物（PCC）の用途別販売量 - プロトロンビン複合体濃縮物（PCC）の用途別売上 - プロトロンビン複合体濃縮物（PCC）の用途別価格 ・北米市場 - 北米のプロトロンビン複合体濃縮物（PCC）市場規模（種類別、用途別） - 主要国別のプロトロンビン複合体濃縮物（PCC）市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのプロトロンビン複合体濃縮物（PCC）市場規模（種類別、用途別） - 主要国別のプロトロンビン複合体濃縮物（PCC）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のプロトロンビン複合体濃縮物（PCC）市場規模（種類別、用途別） - 主要国別のプロトロンビン複合体濃縮物（PCC）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のプロトロンビン複合体濃縮物（PCC）市場規模（種類別、用途別） - 主要国別のプロトロンビン複合体濃縮物（PCC）市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのプロトロンビン複合体濃縮物（PCC）市場規模（種類別、用途別） - 主要国別のプロトロンビン複合体濃縮物（PCC）市場規模（トルコ、サウジアラビア） ・企業情報 CSL、Beijing Tiantan Biological Products、SHANGHAI RAAS、Biotest、Taibang Biologic Group、HUALAN BIOLOGICAL ENGINEERING、WEIGUANG BIOLOGICAL、Green Cross、BOHUI、Guangdong Shuanglin Biopharmaceutical、Jiangxi Boya Bio-Pharmaceutical ・産業チェーン及び販売チャネル分析 - プロトロンビン複合体濃縮物（PCC）の産業チェーン分析 - プロトロンビン複合体濃縮物（PCC）の原材料 - プロトロンビン複合体濃縮物（PCC）の生産プロセス - プロトロンビン複合体濃縮物（PCC）の販売及びマーケティング - プロトロンビン複合体濃縮物（PCC）の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - プロトロンビン複合体濃縮物（PCC）の産業動向 - プロトロンビン複合体濃縮物（PCC）のマーケットドライバー - プロトロンビン複合体濃縮物（PCC）の課題 - プロトロンビン複合体濃縮物（PCC）の阻害要因 ・主な調査結果

Mainly used to treat congenital and acquired coagulation factor II, VII, IX, and X deficiencies (alone or in combination) including: coagulation factor IX deficiency (hemophilia B), and coagulation factor II, VII, X deficiency overdose of anticoagulants, vitamin K deficiency; patients with hemorrhage caused by liver disease need to correct coagulation dysfunction; when disseminated intravascular coagulation (DIC) occurs, coagulation factors II, VII, IX, and X are consumed in large quantities, which can be used in heparin Application after chemotherapeutic; prothrombin time prolongation due to various reasons and intended for surgery, but may be ineffective for those with coagulation factor V deficiency; treatment of bleeding symptoms in patients with hemophilia A who have produced factor VIII preparations ; Reversal of coumarin anticoagulant-induced bleeding.
Market Analysis and Insights: Global Prothrombin Complex Concentrate(PCC) Market
Due to the COVID-19 pandemic, the global Prothrombin Complex Concentrate(PCC) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 100IU accounting for % of the Prothrombin Complex Concentrate(PCC) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hopistial segment is altered to an % CAGR throughout this forecast period.
China Prothrombin Complex Concentrate(PCC) market size is valued at US$ million in 2021, while the US and Europe Prothrombin Complex Concentrate(PCC) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Prothrombin Complex Concentrate(PCC) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Prothrombin Complex Concentrate(PCC) include CSL, Beijing Tiantan Biological Products, SHANGHAI RAAS, Biotest, Taibang Biologic Group, HUALAN BIOLOGICAL ENGINEERING, WEIGUANG BIOLOGICAL, Green Cross and BOHUI, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Prothrombin Complex Concentrate(PCC) Scope and Segment
Prothrombin Complex Concentrate(PCC) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Prothrombin Complex Concentrate(PCC) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
100IU
200IU
300IU
400IU
1000IU
Segment by Application
Hopistial
Clinic
Others
By Company
CSL
Beijing Tiantan Biological Products
SHANGHAI RAAS
Biotest
Taibang Biologic Group
HUALAN BIOLOGICAL ENGINEERING
WEIGUANG BIOLOGICAL
Green Cross
BOHUI
Guangdong Shuanglin Biopharmaceutical
Jiangxi Boya Bio-Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Prothrombin Complex Concentrate(PCC) Product Introduction
1.2 Market by Type
1.2.1 Global Prothrombin Complex Concentrate(PCC) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100IU
1.2.3 200IU
1.2.4 300IU
1.2.5 400IU
1.2.6 1000IU
1.3 Market by Application
1.3.1 Global Prothrombin Complex Concentrate(PCC) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hopistial
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prothrombin Complex Concentrate(PCC) Sales Estimates and Forecasts 2017-2028
2.2 Global Prothrombin Complex Concentrate(PCC) Revenue Estimates and Forecasts 2017-2028
2.3 Global Prothrombin Complex Concentrate(PCC) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Prothrombin Complex Concentrate(PCC) Sales by Region
2.4.1 Global Prothrombin Complex Concentrate(PCC) Sales by Region (2017-2022)
2.4.2 Global Sales Prothrombin Complex Concentrate(PCC) by Region (2023-2028)
2.5 Global Prothrombin Complex Concentrate(PCC) Revenue by Region
2.5.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Region (2017-2022)
2.5.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Prothrombin Complex Concentrate(PCC) Sales by Manufacturers
3.1.1 Global Top Prothrombin Complex Concentrate(PCC) Manufacturers by Sales (2017-2022)
3.1.2 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prothrombin Complex Concentrate(PCC) in 2021
3.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Manufacturers
3.2.1 Global Prothrombin Complex Concentrate(PCC) Revenue by Manufacturers (2017-2022)
3.2.2 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Prothrombin Complex Concentrate(PCC) Revenue in 2021
3.3 Global Prothrombin Complex Concentrate(PCC) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Prothrombin Complex Concentrate(PCC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Prothrombin Complex Concentrate(PCC) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prothrombin Complex Concentrate(PCC) Sales by Type
4.1.1 Global Prothrombin Complex Concentrate(PCC) Historical Sales by Type (2017-2022)
4.1.2 Global Prothrombin Complex Concentrate(PCC) Forecasted Sales by Type (2023-2028)
4.1.3 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2017-2028)
4.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Type
4.2.1 Global Prothrombin Complex Concentrate(PCC) Historical Revenue by Type (2017-2022)
4.2.2 Global Prothrombin Complex Concentrate(PCC) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2017-2028)
4.3 Global Prothrombin Complex Concentrate(PCC) Price by Type
4.3.1 Global Prothrombin Complex Concentrate(PCC) Price by Type (2017-2022)
4.3.2 Global Prothrombin Complex Concentrate(PCC) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Prothrombin Complex Concentrate(PCC) Sales by Application
5.1.1 Global Prothrombin Complex Concentrate(PCC) Historical Sales by Application (2017-2022)
5.1.2 Global Prothrombin Complex Concentrate(PCC) Forecasted Sales by Application (2023-2028)
5.1.3 Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2017-2028)
5.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Application
5.2.1 Global Prothrombin Complex Concentrate(PCC) Historical Revenue by Application (2017-2022)
5.2.2 Global Prothrombin Complex Concentrate(PCC) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2017-2028)
5.3 Global Prothrombin Complex Concentrate(PCC) Price by Application
5.3.1 Global Prothrombin Complex Concentrate(PCC) Price by Application (2017-2022)
5.3.2 Global Prothrombin Complex Concentrate(PCC) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Prothrombin Complex Concentrate(PCC) Market Size by Type
6.1.1 North America Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2028)
6.1.2 North America Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2028)
6.2 North America Prothrombin Complex Concentrate(PCC) Market Size by Application
6.2.1 North America Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2028)
6.2.2 North America Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2028)
6.3 North America Prothrombin Complex Concentrate(PCC) Market Size by Country
6.3.1 North America Prothrombin Complex Concentrate(PCC) Sales by Country (2017-2028)
6.3.2 North America Prothrombin Complex Concentrate(PCC) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Prothrombin Complex Concentrate(PCC) Market Size by Type
7.1.1 Europe Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2028)
7.1.2 Europe Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2028)
7.2 Europe Prothrombin Complex Concentrate(PCC) Market Size by Application
7.2.1 Europe Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2028)
7.2.2 Europe Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2028)
7.3 Europe Prothrombin Complex Concentrate(PCC) Market Size by Country
7.3.1 Europe Prothrombin Complex Concentrate(PCC) Sales by Country (2017-2028)
7.3.2 Europe Prothrombin Complex Concentrate(PCC) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Prothrombin Complex Concentrate(PCC) Market Size by Type
8.1.1 Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2028)
8.1.2 Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2028)
8.2 Asia Pacific Prothrombin Complex Concentrate(PCC) Market Size by Application
8.2.1 Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2028)
8.2.2 Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2028)
8.3 Asia Pacific Prothrombin Complex Concentrate(PCC) Market Size by Region
8.3.1 Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Region (2017-2028)
8.3.2 Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Prothrombin Complex Concentrate(PCC) Market Size by Type
9.1.1 Latin America Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2028)
9.1.2 Latin America Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2028)
9.2 Latin America Prothrombin Complex Concentrate(PCC) Market Size by Application
9.2.1 Latin America Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2028)
9.2.2 Latin America Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2028)
9.3 Latin America Prothrombin Complex Concentrate(PCC) Market Size by Country
9.3.1 Latin America Prothrombin Complex Concentrate(PCC) Sales by Country (2017-2028)
9.3.2 Latin America Prothrombin Complex Concentrate(PCC) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prothrombin Complex Concentrate(PCC) Market Size by Type
10.1.1 Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2028)
10.2 Middle East and Africa Prothrombin Complex Concentrate(PCC) Market Size by Application
10.2.1 Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2028)
10.3 Middle East and Africa Prothrombin Complex Concentrate(PCC) Market Size by Country
10.3.1 Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Overview
11.1.3 CSL Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CSL Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Recent Developments
11.2 Beijing Tiantan Biological Products
11.2.1 Beijing Tiantan Biological Products Corporation Information
11.2.2 Beijing Tiantan Biological Products Overview
11.2.3 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Beijing Tiantan Biological Products Recent Developments
11.3 SHANGHAI RAAS
11.3.1 SHANGHAI RAAS Corporation Information
11.3.2 SHANGHAI RAAS Overview
11.3.3 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 SHANGHAI RAAS Recent Developments
11.4 Biotest
11.4.1 Biotest Corporation Information
11.4.2 Biotest Overview
11.4.3 Biotest Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Biotest Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biotest Recent Developments
11.5 Taibang Biologic Group
11.5.1 Taibang Biologic Group Corporation Information
11.5.2 Taibang Biologic Group Overview
11.5.3 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Taibang Biologic Group Recent Developments
11.6 HUALAN BIOLOGICAL ENGINEERING
11.6.1 HUALAN BIOLOGICAL ENGINEERING Corporation Information
11.6.2 HUALAN BIOLOGICAL ENGINEERING Overview
11.6.3 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments
11.7 WEIGUANG BIOLOGICAL
11.7.1 WEIGUANG BIOLOGICAL Corporation Information
11.7.2 WEIGUANG BIOLOGICAL Overview
11.7.3 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 WEIGUANG BIOLOGICAL Recent Developments
11.8 Green Cross
11.8.1 Green Cross Corporation Information
11.8.2 Green Cross Overview
11.8.3 Green Cross Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Green Cross Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Green Cross Recent Developments
11.9 BOHUI
11.9.1 BOHUI Corporation Information
11.9.2 BOHUI Overview
11.9.3 BOHUI Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 BOHUI Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BOHUI Recent Developments
11.10 Guangdong Shuanglin Biopharmaceutical
11.10.1 Guangdong Shuanglin Biopharmaceutical Corporation Information
11.10.2 Guangdong Shuanglin Biopharmaceutical Overview
11.10.3 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Guangdong Shuanglin Biopharmaceutical Recent Developments
11.11 Jiangxi Boya Bio-Pharmaceutical
11.11.1 Jiangxi Boya Bio-Pharmaceutical Corporation Information
11.11.2 Jiangxi Boya Bio-Pharmaceutical Overview
11.11.3 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prothrombin Complex Concentrate(PCC) Industry Chain Analysis
12.2 Prothrombin Complex Concentrate(PCC) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prothrombin Complex Concentrate(PCC) Production Mode & Process
12.4 Prothrombin Complex Concentrate(PCC) Sales and Marketing
12.4.1 Prothrombin Complex Concentrate(PCC) Sales Channels
12.4.2 Prothrombin Complex Concentrate(PCC) Distributors
12.5 Prothrombin Complex Concentrate(PCC) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Prothrombin Complex Concentrate(PCC) Industry Trends
13.2 Prothrombin Complex Concentrate(PCC) Market Drivers
13.3 Prothrombin Complex Concentrate(PCC) Market Challenges
13.4 Prothrombin Complex Concentrate(PCC) Market Restraints
14 Key Findings in The Global Prothrombin Complex Concentrate(PCC) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Prothrombin Complex Concentrate(PCC) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 100IU
Table 3. Major Manufacturers of 200IU
Table 4. Major Manufacturers of 300IU
Table 5. Major Manufacturers of 400IU
Table 6. Major Manufacturers of 1000IU
Table 7. Global Prothrombin Complex Concentrate(PCC) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Prothrombin Complex Concentrate(PCC) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Prothrombin Complex Concentrate(PCC) Sales by Region (2017-2022) & (K Units)
Table 10. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Region (2017-2022)
Table 11. Global Prothrombin Complex Concentrate(PCC) Sales by Region (2023-2028) & (K Units)
Table 12. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Region (2023-2028)
Table 13. Global Prothrombin Complex Concentrate(PCC) Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Region (2017-2022)
Table 15. Global Prothrombin Complex Concentrate(PCC) Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Region (2023-2028)
Table 17. Global Prothrombin Complex Concentrate(PCC) Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Prothrombin Complex Concentrate(PCC) Sales Share by Manufacturers (2017-2022)
Table 19. Global Prothrombin Complex Concentrate(PCC) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Prothrombin Complex Concentrate(PCC) Revenue Share by Manufacturers (2017-2022)
Table 21. Prothrombin Complex Concentrate(PCC) Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Prothrombin Complex Concentrate(PCC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Prothrombin Complex Concentrate(PCC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prothrombin Complex Concentrate(PCC) as of 2021)
Table 24. Prothrombin Complex Concentrate(PCC) Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Prothrombin Complex Concentrate(PCC) Product Offered
Table 26. Date of Manufacturers Enter into Prothrombin Complex Concentrate(PCC) Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2022) & (K Units)
Table 29. Global Prothrombin Complex Concentrate(PCC) Sales by Type (2023-2028) & (K Units)
Table 30. Global Prothrombin Complex Concentrate(PCC) Sales Share by Type (2017-2022)
Table 31. Global Prothrombin Complex Concentrate(PCC) Sales Share by Type (2023-2028)
Table 32. Global Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Prothrombin Complex Concentrate(PCC) Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Prothrombin Complex Concentrate(PCC) Revenue Share by Type (2017-2022)
Table 35. Global Prothrombin Complex Concentrate(PCC) Revenue Share by Type (2023-2028)
Table 36. Prothrombin Complex Concentrate(PCC) Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Prothrombin Complex Concentrate(PCC) Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2022) & (K Units)
Table 39. Global Prothrombin Complex Concentrate(PCC) Sales by Application (2023-2028) & (K Units)
Table 40. Global Prothrombin Complex Concentrate(PCC) Sales Share by Application (2017-2022)
Table 41. Global Prothrombin Complex Concentrate(PCC) Sales Share by Application (2023-2028)
Table 42. Global Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Prothrombin Complex Concentrate(PCC) Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Prothrombin Complex Concentrate(PCC) Revenue Share by Application (2017-2022)
Table 45. Global Prothrombin Complex Concentrate(PCC) Revenue Share by Application (2023-2028)
Table 46. Prothrombin Complex Concentrate(PCC) Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Prothrombin Complex Concentrate(PCC) Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2022) & (K Units)
Table 49. North America Prothrombin Complex Concentrate(PCC) Sales by Type (2023-2028) & (K Units)
Table 50. North America Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Prothrombin Complex Concentrate(PCC) Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2022) & (K Units)
Table 53. North America Prothrombin Complex Concentrate(PCC) Sales by Application (2023-2028) & (K Units)
Table 54. North America Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Prothrombin Complex Concentrate(PCC) Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Prothrombin Complex Concentrate(PCC) Sales by Country (2017-2022) & (K Units)
Table 57. North America Prothrombin Complex Concentrate(PCC) Sales by Country (2023-2028) & (K Units)
Table 58. North America Prothrombin Complex Concentrate(PCC) Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Prothrombin Complex Concentrate(PCC) Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2022) & (K Units)
Table 61. Europe Prothrombin Complex Concentrate(PCC) Sales by Type (2023-2028) & (K Units)
Table 62. Europe Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Prothrombin Complex Concentrate(PCC) Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2022) & (K Units)
Table 65. Europe Prothrombin Complex Concentrate(PCC) Sales by Application (2023-2028) & (K Units)
Table 66. Europe Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Prothrombin Complex Concentrate(PCC) Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Prothrombin Complex Concentrate(PCC) Sales by Country (2017-2022) & (K Units)
Table 69. Europe Prothrombin Complex Concentrate(PCC) Sales by Country (2023-2028) & (K Units)
Table 70. Europe Prothrombin Complex Concentrate(PCC) Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Prothrombin Complex Concentrate(PCC) Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Prothrombin Complex Concentrate(PCC) Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Prothrombin Complex Concentrate(PCC) Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Prothrombin Complex Concentrate(PCC) Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Prothrombin Complex Concentrate(PCC) Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Prothrombin Complex Concentrate(PCC) Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Prothrombin Complex Concentrate(PCC) Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Prothrombin Complex Concentrate(PCC) Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Prothrombin Complex Concentrate(PCC) Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue by Country (2023-2028) & (US$ Million)
Table 108. CSL Corporation Information
Table 109. CSL Description and Major Businesses
Table 110. CSL Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. CSL Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. CSL Recent Developments
Table 113. Beijing Tiantan Biological Products Corporation Information
Table 114. Beijing Tiantan Biological Products Description and Major Businesses
Table 115. Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Beijing Tiantan Biological Products Recent Developments
Table 118. SHANGHAI RAAS Corporation Information
Table 119. SHANGHAI RAAS Description and Major Businesses
Table 120. SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. SHANGHAI RAAS Recent Developments
Table 123. Biotest Corporation Information
Table 124. Biotest Description and Major Businesses
Table 125. Biotest Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Biotest Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Biotest Recent Developments
Table 128. Taibang Biologic Group Corporation Information
Table 129. Taibang Biologic Group Description and Major Businesses
Table 130. Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Taibang Biologic Group Recent Developments
Table 133. HUALAN BIOLOGICAL ENGINEERING Corporation Information
Table 134. HUALAN BIOLOGICAL ENGINEERING Description and Major Businesses
Table 135. HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. HUALAN BIOLOGICAL ENGINEERING Recent Developments
Table 138. WEIGUANG BIOLOGICAL Corporation Information
Table 139. WEIGUANG BIOLOGICAL Description and Major Businesses
Table 140. WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. WEIGUANG BIOLOGICAL Recent Developments
Table 143. Green Cross Corporation Information
Table 144. Green Cross Description and Major Businesses
Table 145. Green Cross Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. Green Cross Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Green Cross Recent Developments
Table 148. BOHUI Corporation Information
Table 149. BOHUI Description and Major Businesses
Table 150. BOHUI Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. BOHUI Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. BOHUI Recent Developments
Table 153. Guangdong Shuanglin Biopharmaceutical Corporation Information
Table 154. Guangdong Shuanglin Biopharmaceutical Description and Major Businesses
Table 155. Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 156. Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Guangdong Shuanglin Biopharmaceutical Recent Developments
Table 158. Jiangxi Boya Bio-Pharmaceutical Corporation Information
Table 159. Jiangxi Boya Bio-Pharmaceutical Description and Major Businesses
Table 160. Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 161. Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Jiangxi Boya Bio-Pharmaceutical Recent Developments
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Prothrombin Complex Concentrate(PCC) Distributors List
Table 166. Prothrombin Complex Concentrate(PCC) Customers List
Table 167. Prothrombin Complex Concentrate(PCC) Market Trends
Table 168. Prothrombin Complex Concentrate(PCC) Market Drivers
Table 169. Prothrombin Complex Concentrate(PCC) Market Challenges
Table 170. Prothrombin Complex Concentrate(PCC) Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Prothrombin Complex Concentrate(PCC) Product Picture
Figure 3. Global Prothrombin Complex Concentrate(PCC) Market Share by Type in 2021 & 2028
Figure 3. 100IU Product Picture
Figure 4. 200IU Product Picture
Figure 5. 300IU Product Picture
Figure 6. 400IU Product Picture
Figure 7. 1000IU Product Picture
Figure 8. Global Prothrombin Complex Concentrate(PCC) Market Share by Application in 2021 & 2028
Figure 9. Hopistial
Figure 10. Clinic
Figure 11. Others
Figure 12. Prothrombin Complex Concentrate(PCC) Report Years Considered
Figure 13. Global Prothrombin Complex Concentrate(PCC) Sales 2017-2028 (K Units)
Figure 14. Global Prothrombin Complex Concentrate(PCC) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Prothrombin Complex Concentrate(PCC) Revenue 2017-2028 (US$ Million)
Figure 16. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Region (2017-2022)
Figure 18. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Region (2023-2028)
Figure 19. North America Prothrombin Complex Concentrate(PCC) Sales YoY (2017-2028) & (K Units)
Figure 20. North America Prothrombin Complex Concentrate(PCC) Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Prothrombin Complex Concentrate(PCC) Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Prothrombin Complex Concentrate(PCC) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Prothrombin Complex Concentrate(PCC) Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Prothrombin Complex Concentrate(PCC) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Prothrombin Complex Concentrate(PCC) Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Prothrombin Complex Concentrate(PCC) Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Prothrombin Complex Concentrate(PCC) Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Prothrombin Complex Concentrate(PCC) Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Prothrombin Complex Concentrate(PCC) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Prothrombin Complex Concentrate(PCC) in the World: Market Share by Prothrombin Complex Concentrate(PCC) Revenue in 2021
Figure 31. Global Prothrombin Complex Concentrate(PCC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2017-2028)
Figure 33. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2017-2028)
Figure 34. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2017-2028)
Figure 35. Global Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2017-2028)
Figure 36. North America Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2017-2028)
Figure 37. North America Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2017-2028)
Figure 38. North America Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2017-2028)
Figure 39. North America Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2017-2028)
Figure 40. North America Prothrombin Complex Concentrate(PCC) Sales Share by Country (2017-2028)
Figure 41. North America Prothrombin Complex Concentrate(PCC) Revenue Share by Country (2017-2028)
Figure 42. United States Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2017-2028)
Figure 45. Europe Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2017-2028)
Figure 46. Europe Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2017-2028)
Figure 47. Europe Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2017-2028)
Figure 48. Europe Prothrombin Complex Concentrate(PCC) Sales Share by Country (2017-2028)
Figure 49. Europe Prothrombin Complex Concentrate(PCC) Revenue Share by Country (2017-2028)
Figure 50. Germany Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 51. France Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Prothrombin Complex Concentrate(PCC) Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Prothrombin Complex Concentrate(PCC) Revenue Share by Region (2017-2028)
Figure 61. China Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 64. India Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 66. China Taiwan Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2017-2028)
Figure 71. Latin America Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2017-2028)
Figure 73. Latin America Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Prothrombin Complex Concentrate(PCC) Sales Share by Country (2017-2028)
Figure 75. Latin America Prothrombin Complex Concentrate(PCC) Revenue Share by Country (2017-2028)
Figure 76. Mexico Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Prothrombin Complex Concentrate(PCC) Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Prothrombin Complex Concentrate(PCC) Revenue Share by Country (2017-2028)
Figure 85. Turkey Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Prothrombin Complex Concentrate(PCC) Revenue (2017-2028) & (US$ Million)
Figure 88. Prothrombin Complex Concentrate(PCC) Value Chain
Figure 89. Prothrombin Complex Concentrate(PCC) Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

---